Welcome to our dedicated page for Horizon Techn news (Ticker: HRZN), a resource for investors and traders seeking the latest updates and insights on Horizon Techn stock.
Horizon Technology Finance Corporation (HRZN) provides venture lending and growth-capital financing to development-stage and growth companies in technology, life science, healthcare information and services, and sustainability. Its recurring announcements address secured loan facilities, portfolio activity, net investment income and NAV, monthly cash distributions and special distributions, and capital allocation by its board.
Company updates also cover its external management by Horizon Technology Finance Management LLC, affiliation with Monroe Capital, the completed merger with Monroe Capital Corporation, and the HRZN CRFH LLC joint venture focused on growth financing for small- and micro-cap public companies.
On January 11, 2022, Horizon Technology Finance Corporation (NASDAQ: HRZN) announced the closure of a $30 million venture loan facility to Interior Define, Inc. Horizon provided $12.5 million of the initial $20 million draw, while a managed private investment vehicle funded $7.5 million. This funding supports Interior Define, a customizable D2C furniture brand, in its growth, including the opening of 30 new retail locations in 2022. The loan will enhance their product offerings and improve customer experience through an omnichannel approach.
IMV Inc. (NASDAQ: IMV) has secured a US$25 million long-term debt facility led by Horizon Technology Finance Corporation (NASDAQ: HRZN). The company has accessed US$15 million immediately, with an additional US$10 million contingent on meeting a milestone. This financing bolsters funding for clinical development of IMV’s lead candidate, maveropepimut-S (MVP-S), and supports ongoing projects using their DPX technology platform. Proceeds will also settle existing loans, enhancing IMV's financial flexibility.
Horizon Technology Finance Corporation (NASDAQ: HRZN) has granted a $5 million venture loan to Everstream Analytics, enhancing its support for the supply chain risk management software provider. Everstream, an established portfolio company, aims to utilize the funds for general growth and working capital. The loan comes at a critical time as global supply chain disruptions heighten the demand for Everstream's AI-powered analytics. Horizon's commitment emphasizes the potential for Everstream's software to aid businesses in navigating ongoing global logistical challenges.
Horizon Technology Finance Corporation (NASDAQ: HRZN) has announced monthly cash distributions of $0.10 per share for January, February, and March 2022, along with a special distribution of $0.05 per share in December 2021, totaling $0.35 per share. Since its IPO in 2010, Horizon has paid $166 million in distributions to shareholders. The company aims to maximize returns through secure loans to venture capital-backed firms in several industries, including technology and healthcare.
Horizon Technology Finance Corporation (NASDAQ: HRZN) reported strong third quarter results for 2021, achieving a net investment income of $8.0 million, or $0.40 per share, up from $5.9 million or $0.34 per share a year prior. The total investment portfolio reached $452.3 million. The company funded 15 loans totaling $98.9 million and declared monthly distributions of $0.10 per share for January, February, and March 2022, along with a special distribution of $0.05 per share for December 2021. The company's net asset value stands at $237.6 million, or $11.63 per share.
Horizon Technology Finance Corporation (NASDAQ: HRZN) announced its plans to release third-quarter financial results on October 26, 2021, after market close. A conference call to discuss these results is scheduled for October 27, 2021, at 9:00 a.m. ET, featuring remarks from key executives including CEO Robert D. Pomeroy, Jr. Investors can participate via phone or listen through a live webcast on the Company's website. Horizon specializes in providing secured loans to venture capital-backed companies across various sectors including technology and life sciences.
Horizon Technology Finance Corporation (NASDAQ: HRZN) reported strong performance for Q3 2021, achieving a record $141 million in loan originations, with $99 million attributed to HRZN. The portfolio ended with a committed backlog of $123 million, reflecting robust demand for venture loans. During the quarter, HRZN received $50 million in loan prepayments, boosting fee and interest income. The company closed new loan commitments totaling $91 million, with a significant pipeline of opportunities, suggesting ongoing growth potential for shareholders.
Stealth BioTherapeutics (Nasdaq: MITO) completed a $25 million long-term debt facility with Horizon Technology Finance (Nasdaq: HRZN), drawing down $15 million initially. An additional $10 million is contingent on achieving a predetermined milestone. This financing aims to support ongoing clinical trials, including a recent NDA submission for Barth syndrome under FDA review. The facility includes terms for monthly repayments over 48 months, with a potential extension for the interest-only period. Stealth has issued warrants for 13,636,364 shares to Horizon at $0.11 per share.
Horizon Technology Finance will participate in the 20th Annual Capital Link Closed-End Funds & Global ETFs Forum on October 5, 2021, at 2:00 p.m. ET. CEO Robert D. Pomeroy Jr. will join the BDCs Roundtable – Financing America's Growth panel. The conference is free and aims to offer insights from leading venture debt BDC executives. Horizon specializes in providing secured loans to venture capital-backed companies in sectors like technology and life sciences, focusing on maximizing returns from debt investments and capital appreciation.
Horizon Technology Finance Corporation (NASDAQ: HRZN) announced a $30 million venture loan facility to Dropoff, Inc., with Horizon funding $12.5 million of the initial $20 million draw. Dropoff specializes in same-day delivery services for healthcare, utilizing proprietary logistics software for optimized operations. The funding will support Dropoff's working capital and acquisitions. Horizon's President emphasized the company's commitment to supporting Dropoff's growth, as it meets critical delivery needs within the healthcare sector.